• Cytochalasin B (NSC 107658): Powering Cytoskeletal Research

  2026-07-21

  Cytochalasin B (NSC 107658) is a precision cytoskeletal research tool enabling reversible actin filament disruption for powerful mechanistic assays. Discover how recent findings in invertebrate cell models and practical workflow enhancements position this APExBIO reagent as a gold standard for dissecting cell motility and pathogen entry.

• MK-4827 (Niraparib): Protocols and Innovations in Cancer Res

  2026-07-21

  MK-4827 (Niraparib) enables precise DNA damage repair inhibition in BRCA-mutant and resistant cancer models. This guide delivers actionable workflows, advanced troubleshooting, and the latest combination strategies—including hyperthermia synergy—for maximizing PARP inhibitor research outcomes.

• Capsazepine: Unraveling TRPV1 Antagonism in Nociception and

  2026-07-20

  Explore how Capsazepine, a potent TRPV1 ion channel antagonist, uniquely enables advanced mechanistic research on pain signaling and apoptosis in cancer. This article offers critical analysis, protocol insights, and guidance for assay design beyond standard workflows.

• A High-Throughput BBB Model: Predicting CNS Drug Permeabilit

  2026-07-20

  The referenced study presents a robust, high-throughput in vitro blood-brain barrier (BBB) model using LLC-PK1-MOCK/MDR1 cells, integrating a correction for lysosomal trapping. This approach allows accurate prediction of CNS drug permeability, streamlining early-stage screening and improving translational prospects for neurological therapeutics.

• Polymeric mRNA Vectors: Achieving Stability and Delivery Eff

  2026-07-19

  This article reviews the rational design of polymeric mRNA delivery vectors, focusing on the '4Q' principle that integrates storage stability, diffusion, cellular entry, and intracellular release for enhanced gene expression. The study demonstrates how a novel polycatechol-based polymer enables superior room-temperature stability and delivery efficiency, offering guidance for researchers developing mRNA-based assays and therapies.

• Adefovir (GS-0393): Optimizing HBV Antiviral Workflows in Re

  2026-07-18

  Adefovir (GS-0393) empowers hepatitis B virus research with high selectivity, robust inhibition of HBV DNA polymerase, and proven reliability as a probe substrate for OAT1 studies. This article presents actionable protocols, troubleshooting strategies, and critical insights from recent clinical and laboratory findings—enabling reproducible and translational results using APExBIO’s high-purity Adefovir.

• Tofacitinib (CP-690550): Advancing Immune Modulation Workflo

  2026-07-17

  Tofacitinib (CP-690550) is redefining immune modulation research by enabling precise inhibition of interleukin signaling and mitochondrial repair in challenging inflammatory disease models. Explore advanced experimental workflows and troubleshooting strategies that leverage its unique JAK1/JAK3 selectivity and robust cytokine blockade.

• Hyperthermia Sensitizes BRCA2-Proficient Ovarian Cancer to P

  2026-07-17

  A recent study by Mei et al. demonstrates that hyperthermia-induced reduction of BRCA2 protein restores sensitivity to PARP inhibitors in BRCA2-proficient ovarian cancer models. This finding provides a mechanistically grounded, practical strategy to expand the therapeutic scope of PARP inhibitors beyond BRCA-mutant cancers.

• Chemoproteomic Mapping Reveals CDK4 Phosphorylation of 4E-BP

  2026-07-16

  Mitchell et al. developed a chemoproteomic assay to identify kinase-substrate interactions with phosphosite precision, uncovering CDK4's role in phosphorylating 4E-BP1 and modulating cap-dependent translation in breast cancer cells. These findings clarify mechanisms of resistance to mTORC1 inhibitors and suggest new approaches to target translational control in cancer.

• Mechanisms of Saposin B-Mediated Substrate Presentation to α

  2026-07-16

  This study elucidates how human saposin B (SapB) binds and presents glycosphingolipid substrates, specifically Gb3, to α-galactosidase A. Using a combination of fluorescence binding assays, crystallography, and cross-linking, the authors define the molecular basis for SapB's role in lysosomal enzyme activation, with implications for understanding lysosomal storage diseases such as Fabry disease.

• Chloroquine in Translational Research: Pathways, Precision,

  2026-07-15

  Explore the multifaceted roles of Chloroquine as N4-(7-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine in disease modeling and antiviral assays. Delve into its mechanistic breadth, evidence-based dosing, and how emerging insights reshape research protocols.

• Smg5-Dependent NMD Regulates Oligodendrocyte Differentiation

  2026-07-15

  This study uncovers how the RNA surveillance factor Smg5, through nonsense-mediated mRNA decay (NMD), controls oligodendrocyte maturation via post-transcriptional regulation of Hnrnpl in the CNS. The findings reveal a mechanistic pathway crucial for myelination, linking NMD to alternative splicing of myelin genes and providing new insights for neurodevelopmental research.

• Entinostat (MS-275): Epigenetic Control Beyond Oncology

  2026-07-14

  Discover how Entinostat (MS-275) advances cancer research through selective HDAC1/3 inhibition and reveals new insights into regeneration biology. Uncover unique applications, mechanistic depth, and practical guidance for leveraging this oral HDAC inhibitor in experimental workflows.

• BAPTA-AM: Unraveling Calcium-Dependent BDNF Release in Muscl

  2026-07-14

  Explore how BAPTA-AM, a leading cell-permeable calcium chelator, enables precise dissection of localized, calcium-dependent BDNF release in skeletal muscle. This article reveals advanced strategies for leveraging BAPTA-AM in neuromuscular research, setting a new benchmark beyond prior content.

• Perifosine (SKU A8309): Reliable Akt Pathway & Apoptosis Ass

  2026-07-13

  This article addresses common laboratory challenges in apoptosis, cell viability, and Akt/mTOR pathway assays, focusing on Perifosine (SKU A8309) as a validated and reproducible tool. Scenario-driven guidance helps researchers optimize protocols and interpret data, with evidence-backed comparisons highlighting why APExBIO's Perifosine is trusted for sensitive and cost-effective workflows.

16865 records 1/1125 page Next 12345 下5页 Last page